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Escherichia coli RNase P is a ribonucleoprotein composed of a large RNA subunit (M1 RNA) and a
small protein subunit (C5 protein). We examined if C5 protein plays a role in maintaining metabolic
stability of M1 RNA. The sequestration of C5 protein available for M1 RNA binding reduced M1 RNA
stability in vivo, and its reduced stability was recovered via overexpression of C5 protein. In
addition, M1 RNA was rapidly degraded in a temperature-sensitive C5 protein mutant strain at
non-permissive temperatures. Collectively, our results demonstrate that the C5 protein metaboli-
cally stabilizes M1 RNA in the cell.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Escherichia coli RNase P was initially characterized as a tRNA
processing enzyme that removes extraneous 50 sequences from
precursor tRNAs to generate mature 50 termini [1]. In addition to
assisting with tRNA processing, RNase P also contributes to the
processing of other non-tRNA substrates (e.g. 4.5S RNA and
tmRNA) and assists with decay of several mRNAs [2–6]. The RNase
P holoenzyme is composed of two subunits, including a large RNA
subunit (M1 RNA, 377 nucleotides) and a small basic protein (C5
protein, 119 amino acids). While M1 RNA can perform catalytic
reactions in the absence of C5 protein in vitro [7], both components
are essential in vivo [8]. C5 protein stabilizes the catalytically ac-
tive conformation of M1 RNA [9,10] and modulates the substrate
speciﬁcity of the RNase P reaction [11–16].
M1 RNA is a metabolically stable RNA [17,18]. However, it has
not yet been known whether M1 RNA is intrinsically stable or
whether this RNA requires additional factors to maintain its stabil-
ity. Since the depletion of one or more proteins that are part of
ribonucleoprotein complexes can decrease the endogenous level
of their RNA components [19], C5 protein could be a factor re-
quired for metabolic stability of M1 RNA. Studies with tempera-
ture-sensitive C5 protein mutant E. coli strains demonstrated that
cell growth at the non-permissive temperature results in substan-
tially reduced M1 RNA levels compared to wild-type cells [20,21].
In addition, it has recently been shown that overexpression ofchemical Societies. Published by E
).RNase P protein leads to increased steady-state levels of RNase P
RNA in Bacillus subtilis [22]. However, these studies provide no di-
rect evidence of the involvement of C5 protein in the maintenance
of the metabolic stability of M1 RNA, because the cellular RNA lev-
els could be affected by an alteration of transcription.
In this study, we sought to determine if C5 protein is required
for the metabolic stability of M1 RNA using a new approach where
C5 protein is sequestered by overexpression of enzymatically
defective but C5 protein-binding-competent variants of M1 RNA.
Our ﬁndings revealed that C5 protein metabolically stabilizes M1
RNA in vivo. This phenomenon of C5 protein-dependent M1 RNA
stability, although observed before, has never been investigated
in such detail.2. Materials and methods
2.1. Bacterial strains and plasmids
The E. coli K-12 strain JM109 was used for plasmid propagation
and RNA analysis. The E. coli temperature-sensitive C5 protein mu-
tant isogenic strains NHY312 (rnpA+) and NHY322 (rnpA49) [21]
were also used for RNA analysis. Plasmid pLM1, a derivative of
the pGEM3 vector, which contains the rnpB sequence with ﬂanking
sequences spanning positions –270 to +1286 [23], was used to con-
struct additional plasmids capable of overexpressing truncated M1
RNAs. The deletions were introduced by gene splicing via overlap
extension (SOEing) PCR mutagenesis, as previously described
[24], to generate plasmids, pLMdP3, pLMdP8/9, and pLMdP12.
The C5 protein-expressing plasmid, pACTC5, was a derivative oflsevier B.V. All rights reserved.
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rnpB-containing fragments in the pLM plasmid series were also
cloned into the BamHI-HindIII sites of pACYC184 to generate pA-
CYC derivatives that overexpressed truncated M1 RNAs. The prim-
ers used in this study are described in Table 1. Plasmid pMC5 [26]
was used to express C5 protein as a fusion with maltose-binding
protein (MBP).
2.2. In vitro transcription of RNA
DNA templates used for the in vitro transcription of M1 RNA
and truncated M1 RNA derivatives were obtained by PCR from
pLM1 or corresponding deletion plasmids (Table 1). In vitro tran-
scription was performed using T7 RNA polymerase and RNA was
puriﬁed by gel elution. The in vitro transcripts contained extra
GG sequences at their 50 ends.
2.3. Gel mobility shift assays
MBP-C5 protein was puriﬁed from cell containing pMC5 and gel
mobility shift assays between MBP-C5 protein and the truncated
M1 RNA derivatives were performed, as previously described [27].
2.4. Preparation of RNA bound to MBP-C5 protein
JM109 cells containing both pMC5 and a pACYC184 derivative
that overexpressed truncated M1 RNA were grown to an A600 of
0.5. Expression and puriﬁcation of MBP-C5 protein were carried
out, as described previously [28], except that cell extracts were
prepared by grinding the cell pellet with alumina in the presence
of 10 mM ribonucleoside vanadyl complex (NEB) and protease
inhibitor cocktail (Pharmacia).
2.5. Total cellular RNA preparation
JM109 cells containing plasmids were grown overnight (37 C)
in LB containing ampicillin (50 mg/ml) or tetracycline (25 lg/ml),
diluted 1:100 in the same medium, and grown to an A600 of
approximately 0.5 at 37 C. When necessary, expression of C5 pro-
tein was induced via the addition of 0.1 mM IPTG, followed by
10 min incubation. For RNA stability assays, rifampicin (150 lg/
ml) was added to the cultures to stop transcription. Cultures were
then analyzed at different time intervals. In case of rnpA49 isogenic
strains, cells were grown overnight at 30 C, diluted (1:100) into
the fresh media, and grown to an A600 of 0.25. Cultures were di-Table 1
Sequences of the oligonucleotides used in this study.
Names Sequences (50–30)
1_pLM1 GGG GTACCGATTGGTGTCGCAAAC G
4_pLM1 CGAATTCTCCGGACAATGGCTTTGAGG
2_P3 GCCCTATGGAGCCCGGACTTTCCTCGCGACTGTC
3_P3 GAGGAAAGTCCGGGCTCCATAGGGC
2_P8/9 CGGTTTGCTCTCTGTTGCACTGGTCCACCCTGCC
3_P8/9 GACCAGTGCAACAGAGAGCAAACCG
2_P12 TGCGCTCTTACCGCACCCTTTCACCGTTTGCTC T
3_P12 GGTGAAAGGGTGCGGTAAGAGCGCA
5_pACYC GAGGATCCCCGGGTACCGATTGGTGTC
6_pACYC CCCAAGCTTCCGGACAATGGCTTTGAGG
T7-M1(+1) AGGTAATACGACTCACTATAGGGAAGCTGACCAG
M1 (+377) AGGTGAAACT GACCGATAAG CCGGGTTC
Anti-rnpB-P3 GTCTCCCCCGAAGAGGACGACGACG
Anti-rnpB-P8 GGTTTCCCCCCCAGGCGTTACCTGG
Anti-rnpB-P12 GATCCCGCTTGCGCGGGCCATC
Anti-tRNATyr ATTTACAGTCTGCTCCCTTTGGCCGCT
Anti-tRNAPhe GGACTCGGAATCGAACCAAG
Anti-6S CCGACCGGTATTTCTCTGAGATGTTCGCA
Anti-5S CGGCATGGGGTCAGGTGGvided and incubated at 43 C for 10 min before the rifampicin
treatment. Total cellular RNA was prepared by hot phenol extrac-
tion, as described previously [23].
2.6. Northern blot analysis
The RNA samples were subjected to Northern blot analysis, as
described previously [18]. The probes used for the M1 RNA detec-
tion were an anti-M1 RNA riboprobe [23], or stem-speciﬁc oligonu-
cleotide probes. The stem-speciﬁc probes were used to detect
intact M1 RNA, but not truncated derivatives. tRNA, 6S RNA and
5S RNA were analyzed with antisense oligonucleotide probes
(Table 1). The internally 32P-labeled anti-M1 RNA riboprobe was
prepared by T7 RNA polymerase using the HindIII-treated pLMd23
as a template [23]. Oligonucleotide probes were 32P-labeled at
their 50 ends.
2.7. Immunoblot analysis
Total cell lysates or the puriﬁed MBP-C5 protein fractions were
subjected to immunoblot analysis using C5 protein-speciﬁc anti-
body. Antibody to C5 protein, generated by coupling residues 57–
71 to bovine serum albumin, was provided by Ab Frontier.
2.8. Cell growth analysis
A single colony from each strain was inoculated into 1.5 ml LB
containing ampicillin (50 lg/ml). The overnight culture was then
diluted 1:100 in 30 ml of fresh medium containing ampicillin
(50 lg/ml) in a 250-ml Erlenmeyer ﬂask and continued to be
grown at 37 C. Cell growth was monitored by recording A600 val-
ues at various times.
3. Results
3.1. Overexpression of truncated M1 RNA decreases the metabolic
stability of M1 RNA
To determine if C5 protein affects metabolic stability of M1
RNA, we sequestered C5 protein available for M1 RNA binding
in vivo . We hypothesized that overexpression of a competitor
RNA for C5 protein binding would reduce the amount of C5 protein
available for the formation of the RNase P holoenzyme. To test this
hypothesis, ﬁrst, we constructed plasmids overexpressing P3-, P8/
9- and P12-deleted M1 RNA derivatives (Fig. 1). The P3 domain ofDescription
Generation of deleted rnpB
Generation of deleted rnpB
TGGTCAGC Generation of P3-deleted rnpB
Generation of P3-deleted rnpB
CTATGG AGCC Generation of P8/9-deleted rnpB
Generation of P8/9-deleted rnpB
CTGTTGCACTG Generation of P12-deleted rnpB
Generation of P12-deleted rnpB
Cloning of deleted rnpB into pACYC184
Cloning of deleted rnpB into pACYC184
ACAGTC DNA template for in vitro transcription
DNA template for in vitro transcription
Stem-speciﬁc probe
Stem-speciﬁc probe
M1 RNA probe
tRNATyr probe
tRNAPhe probe
6S RNA probe
5S RNA probe
Fig. 1. Deleted regions in the truncated M1 RNA derivatives. Deletion regions
(dotted circle) within the truncated M1 RNA derivatives are indicated in the
secondary structure of M1 RNA [29].
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whereas the P8/9 and P12 regions are not essential for the interac-
tion [30,31]. We assessed binding of these truncated M1 RNA
derivatives to C5 protein. Electrophoretic gel mobility assays with
MBP-C5 protein revealed that P8/9-deleted M1 RNA had a binding
afﬁnity similar to that of intact M1 RNA. However, binding afﬁnity
was very poor in P3-deleted M1 RNA (Fig. 2A). Unfortunately, weFig. 2. Binding of truncated M1 RNA derivatives to C5 protein. (A) 32P-labeled M1
RNA derivatives (0.5 nM) were incubated with increasing amounts of MBP-C5
protein, as indicated. Electrophoretic gel mobility shift assays were performed to
assess interactions between RNA and protein. (B) MBP-C5 protein was puriﬁed from
lysates of cells overexpressing both truncated M1 RNA and MBP-C5 protein. RNA
extracted from the puriﬁed protein, or RNA extracted from the cell lysates as total
cellular RNA, was subjected to Northern blot analysis using an anti-M1 probe. The
following RNAs were overexpressed: P3, P3-deleted M1 RNA; P8/9, P8/9-deleted
M1 RNA; P12, P12-deleted M1 RNA; M1, intact M1 RNA; pA, vector (pACYC184)
control. The contents of MBP-C5 protein in the puriﬁed fractions or lysates were
also assessed via immunoblot analysis using C5 protein-speciﬁc antibody.were not able to generate a reproducible binding afﬁnity for P12-
deleted M1 RNA, as this RNAwas partially degraded during incuba-
tion with the MBP-C5 fusion protein (data not shown). Instead, we
assessed the binding ability of P12-deleted M1 RNA to C5 protein
in the cell (Fig. 2B). The MBP-C5 protein was puriﬁed from E. coli
cells overexpressing both MBP-C5 protein and truncated M1 RNAs.
Truncated M1 RNAs bound to the puriﬁed MBP-C5 protein were
examined via northern blot analysis. High concentrations of P12-
deleted M1 RNA and P8/9-deleted RNA were observed to bind to
the MBP-C5 protein, whereas the signal of P3-deleted M1 RNA re-
mained very low. These data as well as in vitro binding analysis as-
sured that overexpression of the P8/9- and P12-deleted M1 RNA
derivatives could sequester C5 protein available for M1 RNA bind-
ing within cells.
We then investigated the stability of M1 RNA in cells over-
expressing truncated M1 RNA derivatives (Fig. 3). In cells over-
expressing P3-deleted M1 RNA and control cells, the t1/2 values
of endogenous M1 RNA were 39 and 59 min, respectively. How-
ever, the t1/2 values in cells overexpressing P8/9- or P12-deleted
M1 RNA decreased to 10 and 8.6 min, respectively. These data indi-
cate that the sequestration of C5 protein via overexpression of C5
protein-interacting RNA reduces the metabolic stability of M1 RNA.
3.2. Overexpression of C5 protein restores the metabolic stability
of M1 RNA
We analyzed the metabolic stability of M1 RNA in cells co-over-
expressing truncated M1 RNA derivatives and C5 protein (Fig. 4).
C5 protein was overexpressed via IPTG induction of pACTC5. Co-
overexpression of C5 protein restored the metabolic stability of
M1 RNA in cells overexpressing P8/9- or P12-deleted M1 RNA. Ex-
cess C5 protein also slightly increased the metabolic stability of M1
RNA in cells overexpressing P3-deleted variants or control cells.
These data clearly support the role of C5 protein in the metabolic
stabilization of M1 RNA in vivo.
3.3. The mutation rnpA49 decreases the metabolic stability of M1 RNA
To further conﬁrm that C5 protein is required for M1 RNA sta-
bility, we used an rnpA49 strain carrying the thermosensitive mu-
tant phenotype in C5 protein function [32]. At 43 C (non-
permissive temperature), the half-life of M1 RNA in rnpA49 cells
signiﬁcantly decreased with the value of 7.3 min, compared to
40 min in rnpA+ cells (Fig. 5). This result shows that functional C5
protein is required for M1 RNA stability in vivo, in line with previ-
ous ﬁndings [20]. It has been proposed that the rnpA49 mutation
leads to a defect in the assembly of the mutant C5 protein into
RNase P holoenzyme at the non-permissive temperature [33], be-
cause the temperature-sensitive phenotype of rnpA49 cells is com-
plemented by expression of excess M1 RNA [20], and the addition
of excess M1 RNA to in vitro RNase P reconstitution reactions with
the mutant C5 protein increases its enzymatic activity [33]. Thus,
our data suggest that assembly of RNase P holoenzyme is essential
for maintaining the metabolic stability of M1 RNA in the cell.
3.4. C5 protein depletion retards tRNA processing and cell growth
We examined how depletion of C5 protein might affect the cat-
alytic activity of RNase P in vivo (Fig. 6A). Northern blot analysis of
total RNA isolated from cells overexpressing P8/9- or P12-deleted
M1 RNA derivatives revealed some defects in tRNATyr and tRNAPhe
processing with accumulation of their precursors, whereas these
defects were not observed in cells overexpressing P3-deleted M1
RNA. We further examined the growth of cells overexpressing
P8/9- or P12-deleted M1 RNA (Fig. 6B). Growth was slower in these
cells, compared with cells overexpressing the P3-deleted M1 RNA
Fig. 3. Analysis of M1 RNA stability in cells overexpressing truncated M1 RNA derivatives. (A) Effects of overexpressing the truncated M1 RNA derivatives on the metabolic
stability of endogenous M1 RNAs. Total cellular RNA was isolated from cells containing plasmids at the indicated times after the rifampicin treatment. RNAs were subjected to
Northern blot analysis using stem-speciﬁc probes covering the deletion region of the corresponding plasmid-encoded M1 RNA variant to quantitate endogenous M1 RNA
exclusively. Each truncated RNA does not hybridize with the corresponding stem-speciﬁc probe due to the stem deletion. Each RNA sample was analyzed along with RNA
from cells containing the empty vector pGEM3 in the same Northern ﬁlter. (B) The band intensity of endogenous M1 RNA was normalized to that of 6S RNA. The remaining
RNA (% of initial level) was calculated as a ratio of the amount of RNA at each indicated time to the amount of RNA at the rifampicin addition point. (C) The t1/2 values were
determined by linear regression of data obtained from four independent experiments. (D) Possible mechanism of M1 RNA instability via the overexpression of P8/9- or P12-
deleted M1 RNA. When overexpressed RNA sequesters C5 protein, free M1 RNA is rapidly degraded.
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from less RNase P activity.4. Discussion
In this study, we examined the role of C5 protein in the meta-
bolic stability of E. coli M1 RNA. We developed a novel method
for sequestration of C5 protein in the cell. Reducing the amount
of C5 protein available for RNase P holoenzyme assembly de-
creased the metabolic stability of M1 RNA and reduced the half-life
of this RNA from 60 min to 10 min. Therefore, C5 protein appears
to be required for the metabolic stability of M1 RNA in vivo. In
addition, M1 RNA is rapidly degraded in rnpA49 cells at the non-
permissive temperature when C5 protein is not functional [20]
(Fig. 5). This ﬁnding further supports the role of C5 protein in the
maintenance of M1 RNA stability. It has been well established that
C5 protein play roles in stabilizing the catalytically active confor-
mation of the ribozyme M1 RNA [9,10] and modulating the sub-
strate speciﬁcity [11–15]. Therefore, our results suggest that C5
protein functions not only as a cofactor in the ribozyme reactions,
but also as a metabolic stabilizer of M1 RNA in vivo.
In light of our ﬁndings, we propose a working model for the sta-
bilization of M1 RNA (Fig. 7). First, M1 RNA is transcribed from
rnpB. The primary transcript, pM1 RNA, is then processed at the
30 end to generate M1 RNA [23,34,35]. The pM1 RNA is metaboli-
cally unstable, with a half-life of 5 min, because of polyadenyla-
tion-dependent degradation at the 30 end [18]. However, this
polyadenylation does not occur when the 30 end undergoes matu-
ration by processing, resulting in a metabolically stable RNA with a
half-life of 60 min. The stability of M1 RNA can be sustained only in
the presence of C5 protein. Without C5 protein, M1 RNA rapidly
degrades with a half-life of 10 min.C5 protein sequestration by overexpression of truncated M1
RNA gave rise to some production of mature tRNA, although pre-
cursor tRNAs accumulated. These data suggest that cells with de-
pleted levels of free C5 protein retained residual RNase P activity,
perhaps by some intact M1 RNAs winning in competition with
truncated derivatives for C5 protein binding. Alternatively, ribonu-
cleoprotein complexes (composed of truncated M1 RNAs and C5
protein) may have retained some catalytic activities [36,37].
It has beenhypothesized that life originated fromanRNA-depen-
dent environment, where RNA operated as the functional molecule
[38]. As life evolved, many of the tasks performed by RNA were
transferred to proteins. In addition, it has been speculated that some
RNP complexes (e.g. RNase P, ribosomes, and spliceosomes) repre-
sent vestiges of the transition from a RNA-driven environment to
the contemporary world of proteins [7,39–42]. During this transi-
tion, proteins were thought to assist with the tasks performed by
RNA molecules, as the protein components of contemporary RNP
complexes function as cofactors, whereas catalytic activities are re-
tained by some RNAs. Given that RNAmolecules are chemically and
biologically unstable, it also remains possible that proteins emerged
in the RNA world during the early evolution of life to prevent the
degradation of RNAmolecules. Our ﬁndings support this possibility
by demonstrating that C5 protein acting as a protein cofactor is also
essential for the stability of M1 RNA.
As C5 protein is only one-tenth the size of M1 RNA, it is very
interesting that this small protein is capable of protecting such a
large RNA molecule from degradation. The site for the initial cleav-
age as a committed step of M1 RNA turnover may exist in the M1
RNA region that interacts with C5 protein. Alternatively, the
cleavage site may be located at another region, as the M1 RNA
structure changes with C5 protein binding and may prevent the
ribonuclease from accessing that site. It is also possible that C5
binding might affect the metabolic stability of M1 RNA by altering
Fig. 4. Effects of C5 protein overexpression on the stability of M1 RNA. (A) The
stability of M1 RNA in cells overexpressing truncated M1 RNA, in conjunction with
overexpression of C5 protein from pACTC5, was examined by Northern blot analysis
using stem-speciﬁc probes. (B) The remaining RNA (% of initial level) was
calculated, as in Fig. 3B. 184, pACYC184; C5, pACTC5; P3, pLMdP3; P8/9, pLMdP8/
9; P12, pLMdP12.
Fig. 5. Stability of M1 RNA in rnpA49 cells. (A) Rifampicin was added to rnpA+ (WT)
and rnpA49 (A49) cells grown at 30 C or 43 C. Total cellular RNA was isolated from
each strain at the indicated times and subjected to Northern blot analysis using the
antisense M1 RNA riboprobe. (B) The remaining RNA (% of initial level) was
calculated, as in Fig. 3B.
Fig. 6. Effects of C5 protein depletion on tRNA processing and cell growth. (A)
Northern blot analysis was performed on total RNAs isolated from cells containing
pLMdP3, pLMdP8/9, or pLMdP12. Membranes were probed with anti-tRNATyr (left)
and anti-tRNAPhe (right) oligonucleotides. (B) Growth of cells overexpressing
truncated M1 RNA derivatives.
Fig. 7. A model for the maintenance of stable M1 RNA in E. coli. A primary rnpB
transcript (pM1 RNA) is metabolically unstable, with a half-life of 5 min. Processing
at the 30 end increases the stability of M1 RNA, resulting in a half-life of 10 min. The
processed product (M1 RNA) binds to C5 protein, forms RNase P holoenzyme and
becomes metabolically stable.
Y. Kim, Y. Lee / FEBS Letters 583 (2009) 419–424 423other rate-determining steps in RNA degradation, such as polyad-
enylation of the 30 end [43] or removal of pyrophosphate at the
50 end [44]. Although the initial cleavage site and the enzymes
responsible for M1 RNA decay remain unknown, the identiﬁcation
of C5 protein as a metabolic stabilizer of M1 RNA provides a tool
that can be used to examine the mechanism by which a protein
protects RNA from degradation in the cell.
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